Your browser doesn't support javascript.
loading
Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy.
Canda, Ebru; Kose, Melis; Kagnici, Mehtap; Ucar, Sema Kalkan; Sozmen, Eser Y; Coker, Mahmut.
Afiliação
  • Canda E; Ege University, Faculty of Medicine, Department of Pediatrics, Division of Metabolism and Nutrition, Turkey. Electronic address: ebru.canda@gmail.com.
  • Kose M; Ege University, Faculty of Medicine, Department of Pediatrics, Division of Metabolism and Nutrition, Turkey. Electronic address: drmelisdemir@gmail.com.
  • Kagnici M; Ege University, Faculty of Medicine, Department of Pediatrics, Division of Metabolism and Nutrition, Turkey. Electronic address: mehtapsanlilar@hotmail.com.
  • Ucar SK; Ege University, Faculty of Medicine, Department of Pediatrics, Division of Metabolism and Nutrition, Turkey. Electronic address: semakalkan@hotmail.com.
  • Sozmen EY; Ege University, Faculty of Medicine, Department of Biochemistry, Turkey. Electronic address: eser.sozmen@ege.edu.tr.
  • Coker M; Ege University, Faculty of Medicine, Department of Pediatrics, Division of Metabolism and Nutrition, Turkey. Electronic address: mahmut.coker@ege.edu.tr.
Blood Cells Mol Dis ; 68: 180-184, 2018 02.
Article em En | MEDLINE | ID: mdl-28111116

Texto completo: 1 Base de dados: MEDLINE Assunto principal: 1-Desoxinojirimicina / Inibidores Enzimáticos / Doença de Gaucher / Glucosilceramidase Limite: Adult / Female / Humans Idioma: En Revista: Blood Cells Mol Dis Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: 1-Desoxinojirimicina / Inibidores Enzimáticos / Doença de Gaucher / Glucosilceramidase Limite: Adult / Female / Humans Idioma: En Revista: Blood Cells Mol Dis Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article